Brentuximab Vedotin Medication Information

Get detailed information on Brentuximab Vedotin, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it.

The updated prescription information on Brentuximab Vedotin provides an overview of possible side effects, precautions, warnings, and storage tips.

You'll also find brand names used in india and internationally, along with pricing details. For further clarification, consult your healthcare provider.

Generic Name : Brentuximab Vedotin

Pronunciation : bren-TUX-i-mab

ICD Code : Y43.3 Therapeutic Classification : Chemotherapy

Trade Names/Brand Names of Brentuximab Vedotin

International :

Adcetris

Why is Brentuximab Vedotin Prescribed? (Indications)

This medication is a monoclonal antibody, prescribed for certain types of lymphoma (Hodgkin lymphoma, systemic anaplastic large cell lymphoma [sALCL]). It works by killing cancer cells.

When should Brentuximab Vedotin not be taken? (Contraindications)

Hypersensitivity.

What is the dosage of Brentuximab Vedotin?

IV- The recommended dose is 1.8 mg/kg, over 30 minutes infusion every 3 weeks.

How should Brentuximab Vedotin be taken?

It comes as a solution for injection, to be administered by a healthcare provider into the vein.

What are the warnings and precautions for Brentuximab Vedotin?

• Caution should be exercised in patients with history of nerve problem, any allergy, who are taking other medications, during pregnancy and breastfeeding.

• It may cause dizziness, do not drive a car or operate machinery while taking this medication.

• It may decrease platelet counts; avoid injury or bruising.

• Avoid contact with people who have infections that may spread to others.

• Patient may develop with increased risk of tumor lysis syndrome (TLS), and viral brain infection (fatal conditions) with the following symptoms: irregular heartbeat, fainting, decreased urination, muscle weakness or cramps, dizziness, difficulty in talking, poor eyesight, nausea, vomiting, diarrhea, or loss of appetite; if it is so consult with your healthcare provider.

What are the side effects of Brentuximab Vedotin?

Most Common - Decrease in white blood cells, anemia, peripheral sensory neuropathy, fatigue, nausea, fever, rash, diarrhea and pain.
Blood - Swelling of lymph nodes and decrease in platelet counts.
Central Nervous system - Headache, sleeplessness, anxiety and dizziness.
General - Chills and swelling in the extremities.
Infections - Upper respiratory tract infection.
Gastrointestinal - Abdominal pain, vomiting and constipation.
Skin - Itching, hair loss, night sweats and dry skin.
Respiratory - Cough, difficulty in breathing and throat pain.
Musculoskeletal - Joint pain, muscle pain, back pain and muscle spasms.
Metabolic - Decreased appetite and weight.